Company intelligence / Profile preview

Sirona Laboratories

Luxembourg

Ownership: Private
Development stage: Other

Overview

Sirona Laboratories, a new subsidiary being established in Luxembourg by Sirona Biochem and Promura GmbH, will focus on commercialization and exclusive distribution of anti-aging products using TFC-1326. No clinical trial data has been published to date; launch is pending strategic investment and ongoing due diligence.

Therapeutic areas: OtherDermatology
Industry: Biotech

Partnerships

Promura GmbH (strategic investor and operational partner)

Beyond the preview

Go deeper on Sirona Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirona Laboratories.

Explore the full profile